| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Department of Orthopaedic Surgery,* Growth and Development Laboratory, Childrens Hospital of Pittsburgh, and the Department of Molecular Genetics and Biochemistry,
University of Pittsburgh, Pittsburgh, Pennsylvania
Injured muscle can initiate regeneration promptly by activating myogenic cells that proliferate and differentiate into myotubes and myofibers. However, the recovery of the injured skeletal muscle often is hindered by the development of fibrosis. We hypothesized that the early-appearing myogenic cells in the injured area differentiate into myofibroblasts and eventually contribute to the development of fibrosis. To investigate this, we transplanted a genetically engineered clonal population of muscle-derived stem cells (MC13 cells) into the skeletal muscle of immunodeficient SCID mice, which were lacerated 4 weeks after transplantation. The MC13 cells regenerated numerous myofibers in the nonlacerated muscle and these myogenic cells were gradually replaced by myofibroblastic cells in the injured muscle. Our results suggest that the release of local environmental stimuli after muscle injury triggers the differentiation of myogenic cells (including MC13 cells) into fibrotic cells. These results demonstrate the potential of muscle-derived stem cells to differentiate into different lineages and illustrate the importance of controlling the local environment within the injured tissue to optimize tissue regeneration via the transplantation of stem cells.
This article has been cited by other articles:
![]() |
H. S. Bedair, T. Karthikeyan, A. Quintero, Y. Li, and J. Huard Angiotensin II Receptor Blockade Administered After Injury Improves Muscle Regeneration and Decreases Fibrosis in Normal Skeletal Muscle Am. J. Sports Med., August 1, 2008; 36(8): 1548 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Gates, T. Karthikeyan, F. Fu, and J. Huard Regenerative Medicine for the Musculoskeletal System Based on Muscle-derived Stem Cells J. Am. Acad. Ortho. Surg., February 1, 2008; 16(2): 68 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, Y. Li, W. Shen, C. Qiao, F. Ambrosio, M. Lavasani, M. Nozaki, M. F. Branca, and J. Huard Relationships between Transforming Growth Factor-beta1, Myostatin, and Decorin: IMPLICATIONS FOR SKELETAL MUSCLE FIBROSIS J. Biol. Chem., August 31, 2007; 282(35): 25852 - 25863. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bedair, T. T. Liu, J. L. Kaar, S. Badlani, A. J. Russell, Y. Li, and J. Huard Matrix metalloproteinase-1 therapy improves muscle healing J Appl Physiol, June 1, 2007; 102(6): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koga, T. Muneta, Y.-J. Ju, T. Nagase, A. Nimura, T. Mochizuki, S. Ichinose, K. von der Mark, and I. Sekiya Synovial Stem Cells Are Regionally Specified According to Local Microenvironments After Implantation for Cartilage Regeneration Stem Cells, March 1, 2007; 25(3): 689 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Negishi, Y. Li, A. Usas, F. H. Fu, and J. Huard The Effect of Relaxin Treatment on Skeletal Muscle Injuries Am. J. Sports Med., December 1, 2005; 33(12): 1816 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shen, Y. Li, Y. Tang, J. Cummins, and J. Huard NS-398, a Cyclooxygenase-2-Specific Inhibitor, Delays Skeletal Muscle Healing by Decreasing Regeneration and Promoting Fibrosis Am. J. Pathol., October 1, 2005; 167(4): 1105 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirano, T. Shimono, K. Imanaka-Yoshida, K. Miyamoto, K. Fujinaga, M. Kajimoto, Y. Miyake, M. Nishikawa, T. Yoshida, A. Uchida, et al. Method of Cell Transplantation Promoting the Organization of Intraarterial Thrombus Circulation, August 30, 2005; 112(9_suppl): I-111 - I-116. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. H. Jarvinen, T. L. N. Jarvinen, M. Kaariainen, H. Kalimo, and M. Jarvinen Muscle Injuries: Biology and Treatment Am. J. Sports Med., May 1, 2005; 33(5): 745 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Chan, Y. Li, W. Foster, F. H. Fu, and J. Huard The Use of Suramin, an Antifibrotic Agent, to Improve Muscle Recovery After Strain Injury Am. J. Sports Med., January 1, 2005; 33(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barbier, M. R. Popoff, and J. Molgo Degeneration and Regeneration of Murine Skeletal Neuromuscular Junctions after Intramuscular Injection with a Sublethal Dose of Clostridium sordellii Lethal Toxin Infect. Immun., June 1, 2004; 72(6): 3120 - 3128. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, W. Foster, B. M. Deasy, Y. Chan, V. Prisk, Y. Tang, J. Cummins, and J. Huard Transforming Growth Factor-{beta}1 Induces the Differentiation of Myogenic Cells into Fibrotic Cells in Injured Skeletal Muscle: A Key Event in Muscle Fibrogenesis Am. J. Pathol., March 1, 2004; 164(3): 1007 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Chan, Y. Li, W. Foster, T. Horaguchi, G. Somogyi, F. H. Fu, and J. Huard Antifibrotic effects of suramin in injured skeletal muscle after laceration J Appl Physiol, August 1, 2003; 95(2): 771 - 780. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |